Automating Heart Failure Prior Authorization for Enhanced Patient Access
Klivira revolutionizes heart failure prior authorization by automating complex workflows, ensuring patients receive timely access to life-saving treatments and procedures.
Managing prior authorizations for heart failure patients presents significant administrative burdens, impacting revenue cycles and delaying critical care. The high volume of specialized medications, advanced diagnostics, and implantable devices necessitates a robust, efficient system to navigate payer requirements and reduce operational friction.
Navigating Complex Heart Failure Prior Authorization Workflows
Heart failure management often involves a spectrum of high-cost medications, advanced imaging, and interventional procedures, each frequently requiring prior authorization. Distinctions between HFpEF and HFrEF, along with evolving guidelines, add layers of complexity, leading to increased manual effort, potential delays, and higher denial rates for essential cardiac care.
Common Heart Failure PA Requirements
- Novel oral anticoagulants and SGLT2 inhibitors
- Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices
- Advanced cardiac imaging (e.g., cardiac MRI, PET scans)
- Heart transplant evaluations and ventricular assist devices (VADs)
- Specialized heart failure clinics and remote patient monitoring programs
Klivira: Intelligent Automation for Cardiac Prior Authorizations
Klivira's platform automates the end-to-end prior authorization process for heart failure cases, from clinical documentation extraction to payer submission and status tracking. By leveraging AI and machine learning, Klivira identifies specific payer rules, compiles necessary clinical data, and streamlines communication, drastically reducing the manual burden on your PA teams.
Accelerating Patient Access and Revenue Capture
Implementing Klivira for heart failure prior authorization translates directly into tangible operational and financial benefits. Clinics and health systems experience reduced PA turnaround times, fewer denials, and improved staff productivity, allowing your teams to focus on patient care rather than administrative tasks. This ensures timely access to critical heart failure treatments and procedures.
Deep Integration for Unified Cardiac Workflows
Klivira integrates directly with leading EMR systems via SMART on FHIR, extracting relevant clinical data points for heart failure diagnoses, medications, and treatment plans. Our platform then communicates with payers through X12 278 transactions and direct portal integrations, aligning with industry standards like Da Vinci PAS for efficient electronic prior authorization (ePA).
Measurable Improvements in Cardiac PA
- Reduced average PA turnaround time for heart failure medications and devices.
- Lower initial denial rates for complex cardiology procedures.
- Increased staff capacity to manage higher patient volumes without additional hires.
- Enhanced compliance with payer-specific documentation requirements.
- Improved patient satisfaction due to expedited treatment approvals.
Frequently asked questions
How does Klivira handle specific heart failure medications requiring PA?
Klivira's AI engine is trained on a vast dataset of payer rules for heart failure medications, including novel therapies like SGLT2 inhibitors and ARNI combinations. It automatically identifies required clinical criteria from the EMR, populates the authorization request, and submits it according to payer specifications, minimizing manual intervention.
What EMRs does Klivira integrate with for cardiology?
Klivira offers robust integration capabilities with major EMR systems, including Epic, Cerner, and Meditech, through standards like SMART on FHIR. This ensures seamless data flow for heart failure patient demographics, diagnoses, and treatment plans directly into the prior authorization workflow.
Can Klivira help with PA for cardiac devices like ICDs or CRTs?
Yes, Klivira supports prior authorization for a wide range of cardiac devices, including ICDs, CRTs, and VADs. The platform streamlines the collection of surgical notes, diagnostic test results, and clinical indications required by payers for device approval, accelerating patient access to these critical interventions.
How does Klivira reduce PA turnaround times for heart failure cases?
By automating data extraction, rules application, and submission, Klivira eliminates manual bottlenecks inherent in traditional PA processes. Our system proactively monitors submission status and flags potential issues, significantly reducing the time from order to approval for heart failure treatments and diagnostics.
Is Klivira compliant with Da Vinci PAS initiatives?
Klivira actively aligns with Da Vinci PAS (Prior Authorization Support) implementation guides, leveraging FHIR-based exchanges to facilitate real-time, electronic prior authorization. This commitment to industry standards ensures interoperability and future-proofs our solution for evolving ePA mandates.
Related coverage
Ready to automate prior auth for this condition?
See how Klivira automates prior authorizations for your team.
Request a demo